Mixed lanthanide oxide nanoparticles as dual imaging agent in biomedicine

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Xu, Wenlong ^a   Bony, Badrul Alam ^a   Kim, Cho Rong ^a   Baeck, Jong Su ^b   Chang, Yongmin ^b   Bae, Ji Eun ^a   Chae, Kwon Seok ^a   Kim, Tae Jeong ^a   Lee, Gang Ho ^a  

^a Kyungpook National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; LANTHANIDE; NANOPARTICLE; OXIDE;

ANIMAL; CELL LINE; DIAGNOSTIC USE; HUMAN; MEDICAL TECHNOLOGY; MOLECULAR IMAGING; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; TUMOR CELL LINE;

ANIMALS; BIOMEDICAL TECHNOLOGY; CELL LINE; CELL LINE, TUMOR; FLUORESCENT DYES; HUMANS; LANTHANOID SERIES ELEMENTS; MAGNETIC RESONANCE IMAGING; MICE; MOLECULAR IMAGING; NANOPARTICLES; OXIDES;

EID: 84887811878     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03210     Document Type: Article

References (65)

1. Wang, G., Peng, Q. & Li, Y. Lanthanide-doped nanocrystals: synthesis, opticalmagnetic properties, and applications. Acc. Chem. Res. 44, 322-332 (2011).
2. Xu,W. et al. AT1, T2 magnetic resonance imaging (MRI)-fluorescent imaging (FI) by using ultrasmall mixed gadolinium-europium oxide nanoparticles. New J. Chem. 36, 2361-2367 (2012).
3. Zhang, Y., Vijayaragavan, V., Das, G. K., Bhakoo, K. K. & Tan, T. T. Y. Singlephase NaDyF4:Tb31 nanocrystals as multifunctional contrast agents in high-field magnetic resonance and optical imaging. Eur. J. Inorg. Chem. 2044-2048 (2012).
4. Das, G. K. et al. Single-phase Dy2O3:Tb31 nanocrystals as dual-modal contrast agent for high field magnetic resonance and optical imaging. Chem. Mater. 23, 2439-2446 (2011).
5. Zhang, L. et al. Multifunctional GdPO4:Eu31 hollow spheres: synthesis and magnetic and luminescent properties. Inorg. Chem. 50, 10608-10613 (2011).
6. Tian, G. et al. Facile fabrication of rare-earth doped Gd2O3 hollow spheres with upconversion luminescence, magnetic resonance, and drug delivery properties. J. Phys. Chem. C 115, 23790-23796 (2011).
7. Li, I.-F. & Yeh, C.-S. Synthesis of Gd doped CdSe nanoparticles for potential optical and MR imaging applications. J. Mater. Chem. 20, 2079-2081 (2010).
8. Zhou, J. et al. Dual-modality in vivo imaging using rare-earth nanocrystals with near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties. Biomaterials 31, 3287-3295 (2010).
9. Shi, Z.,Neoh, K. G., Kang, E. T., Shuter, B.& Wang, S.-C. Bifunctional Eu31-doped Gd2O3 nanoparticles as a luminescent and T1 contrast agent for stem cell labeling. Contrast Media Mol. Imaging 5, 105-111 (2010).
10. Petoral, Jr, R. M. et al. Synthesis and characterization of Tb31-doped Gd2O3 nanocrystals: a bifunctionalmaterial with combined fluorescent labeling and MRI contrast agent properties. J. Phys. Chem. C 113, 6913-6920 (2009).
11. Kim, H., Achermann, M., Balet, L. P., Hollingsworth, J. A. & Klimov, V. I. Synthesis and characterization of Co/CdSe core/shell nanocomposites: bifunctional magnetic-optical nanocrystals. J. Am. Chem. Soc. 127, 544-546 (2005). (Pubitemid 40174379)
12. Gu, H. W., Zheng, R. K., Zhang, X. X. & Xu, B. Facile one-pot synthesis of bifunctional heterodimers of nanoparticles: a conjugate of quantum dot and magnetic nanoparticles. J. Am. Chem. Soc. 126, 5664-5665 (2004). (Pubitemid 38621394)
13. Xu, W. et al. Fluorescein-polyethyleneimine coated gadolinium oxide nanoparticles as T1 magnetic resonance imaging (MRI)-cell labeling (CL) dual agents. RSC Adv. 2, 10907-10915 (2012).
14. Cotton, F. A. & Wilkinson, G. Advanced Inorganic Chemistry, 4th Edn. [983] (John Wiley & Sons, New York, 1980).
15. Wakefield, G., Keron, H. A., Dobson, P. J. & Hutchison, J. L. Synthesis and properties of sub-50-nm europium oxide nanoparticles. J. Colloid Interface Sci. 215, 179-182 (1999). (Pubitemid 29394550)
16. Flores-González, M. A. et al. Elaboration of nanostructured Eu31 -doped Gd2O3 phosphor fine spherical powders using polyol-mediated synthesis. Appl. Phys. A -Mater. Sci. Proc. 81, 1385-1391 (2005). (Pubitemid 41319598)
17. Lewin, M. et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18, 410-414 (2000). (Pubitemid 30217528)
18. Lux, F. et al. Ultrasmall rigid particles as multimodal probes for medical applications. Angew. Chem. Int. Ed. 50, 12299-12303 (2011).
19. Weissleder, R. & Mahmood, U. Molecular imaging. Radiology 219, 316-333 (2001). (Pubitemid 32336342)
20. Paeng, J. C. & Lee, D. S. Multimodal molecular imaging in vivo. Open Nucl. Med. J. 2, 145-152 (2010).
21. Kircher, M. F., Mahmood, U., King, R. S., Weissleder, R. & Josephson, L. A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res. 63, 8122-8125 (2003). (Pubitemid 37549457)
22. Lauffer, R. B. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem. Rev. 87, 901-927 (1987).
23. Caravan, P., Ellison, J. J., McMurry, T. J. & Lauffer, R. B. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem. Rev. 99, 2293-2352 (1999). (Pubitemid 30498114)
24. Roch, A., Muller, R. N. & Gillis, P. Theory of proton relaxation induced by superparamagnetic particles. J. Chem. Phys. 110, 5403-5411 (1999). (Pubitemid 129615822)
25. Kattel, K. et al. A facile synthesis, in vitro and in vivo MR studies of D-glucuronic acid-coated ultrasmall Ln2O3 (Ln 5 Eu, Gd, Dy, Ho, and Er) nanoparticles as a new potential MRI contrast agent. ACS Appl. Mater. Interfaces 3, 3325-3334 (2011).
26. Xu, W. et al. Paramagnetic nanoparticle T1 and T2 MRI contrast agents. Phys. Chem. Chem. Phys. 14, 12687-12700 (2012).
27. Choi, H. S. et al. Renal clearance of quantum dots. Nat. Biotechnol. 25, 1165-1170 (2007).
28. Bünzli, J.-C. G. Lanthanide luminescence for biomedical analyses and imaging. Chem. Rev. 110, 2729-2755 (2010).
29. Eliseeva, S. V. & Bünzli, J.-C. G. Lanthanide luminescence for functional materials and bio-sciences. Chem. Soc. Rev. 39, 189-227 (2010).
30. Michalet, X. et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307, 538-544 (2005). (Pubitemid 40165671)
31. Lin, S. et al. Quantum dot imaging for embryonic stem cells. BMCBiotechnol. 7, 67 (2007).
32. Kovar, J. L., Simpson,M.A., Schutz -Geschwender, A.& Olive, D. M.Asystematic approach to the development of fluorescent contrast agents for optical imaging of mouse cancer models. Anal. Biochem. 367, 1-12 (2007). (Pubitemid 46938663)
33. Wu, S. et al. Non-blinking and photostable upconverted luminescence from single lanthanide-doped nanocrystals. Proc. Natl. Acad. Sci. USA 106, 10917-10921 (2009).
34. Lim, S. F. et al. In vivo and scanning electron microscopy imaging of upconverting nanophosphors in Caenorhabditis elegans. Nano Lett. 6, 169-174 (2006). (Pubitemid 43382946)
35. Chatterjee, D. K., Rufaihah, A. J. & Zhang, Y. Upconversion fluorescence imaging of cells and small animals using lanthanide doped nanocrystals. Biomaterials 29, 937-943 (2008). (Pubitemid 350266053)
36. Sun, S., Murray, C. B., Weller, D., Folks, L. & Moser, A. Monodisperse FePt nanoparticles and ferromagnetic FePt nanocrystal superlattices. Science 287, 1989-1992 (2000). (Pubitemid 30158668)
37. Park, J. et al. Ultra-large-scale syntheses of monodisperse nanocrystals. Nat. Mater. 3, 891-895 (2004).
38. Wang, F. et al. Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping. Nat. 463, 1061-1065 (2010).
39. Söderlind, F., Pedersen, H., Petoral Jr, R. M., Käll, P.-O. & Uvdal, K. Synthesis and characterization of Gd2O3 nanocrystals functionalized by organic acids. J. Colloid Interface Sci. 288, 140-148 (2005). (Pubitemid 40779509)
40. Duckworth, O. W. & Martin, S. T. Surface complexation and dissolution of hematite by C1-C6 dicarboxylic acids at pH55.0. Geochim. Cosmochim. Acta 65, 4289-4301 (2001). (Pubitemid 34021296)
41. Hug, S. J. & Bahnemann, D. Infrared spectra of oxalate, malonate and succinate adsorbed on the aqueous surface of rutile, anatase and lepidocrocite measured with in situ ATR-FTIR. J. Electron Spectrosc. Relat. Phenom. 150, 208-219 (2006). (Pubitemid 41737448)
42. Hug, S. J. & Sulzberger, B. In situ Fourier transform infrared spectroscopic evidence for the formation of several different surface complexes of oxalate on TiO2 in the aqueous phase. Langmuir 10, 3587-3597 (1994).
43. Mendive, C. B., Bredow, T., Blesa, M. A. & Bahnemann, D. W. ATR-FTIR measurements and quantum chemical calculations concerning the adsorption and photoreaction of oxalic acid on TiO2. Phys. Chem. Chem. Phys. 8, 3232-3247 (2006).
44. Corbierre, M. K., Cameron, N. S. & Lennox, R. B. Polymer-stabilized gold nanoparticles with high grafting densities. Langmuir 20, 2867-2873 (2004).
45. Arajs, S. & Colvin, R. V. Paramagnetic susceptibility of Eu2O3 from 300u to 1300uK. J. Appl. Phys. 35, 1181-1183 (1964).
46. Arajs, S. & Colvin, R. V. Magnetic susceptibility of gadolinium and dysprosium sesquioxides at elevated temperatures. J. Appl. Phys. 33, 2517-2519 (1962).
47. Koehler, W. C., Wollan, E. O. & Wilkinson, M. K. Paramagnetic and nuclear scattering cross sections of holmium sesquioxide. Phys. Rev. 110, 37-40 (1958).
48. Lal, H. B., Pratap, V. & Kumar, A. Magnetic susceptibility of heavy rare-earth sesquioxides. Prama-na 10, 409-412 (1978).
49. Bridot, J.-L. et al. Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. J. Am. Chem. Soc. 129, 5076-5084 (2007). (Pubitemid 46651385)
50. Ahrén, M. et al. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement. Langmuir 26, 5753-5762 (2010).
51. Johnson, N. J. J., Oakden,W., Stanisz, G. J., Prosser, R. S. & van Veggel, F. C. J. M. Size-tunable, ultrasmall NaGdF4 nanoparticles: insight into their T1 MRI contrast enhancement. Chem. Mater. 23, 3714-3722 (2011).
52. Kim, T. J., Chae, K. S., Chang, Y. & Lee, G. H. Gadolinium oxide nanoparticles as potential multimodal imaging and therapeutic agents. Curr. Topics Med. Chem. 13, 422-433 (2013).
53. Kattel, K. et al. Paramagnetic dysprosium oxide nanoparticles and dysprosium hydroxide nanorods as T2 MRI contrast agents. Biomaterials 33, 3254-3261 (2012).
54. Norek, M., Kampert, E., Zeitler, U. & Peters, J. A. Tuning of the size of Dy2O3 nanoparticles for optimal performance as an MRI contrast agent. J. Am. Chem. Soc. 130, 5335-5340 (2008). (Pubitemid 351537093)
55. Norek, M. et al. NMR transversal relaxivity of suspensions of lanthanide oxide nanoparticles. J. Phys. Chem. C 111, 10240-10246 (2007). (Pubitemid 47184432)
56. Gossuin, Y. et al. Physico-chemical and NMR relaxometric characterization of gadolinium hydroxide and dysprosium oxide nanoparticles. Nanotechnology 19, 475102 (2008).
57. Park, J. Y. et al. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images. ACS Nano 3, 3663-3669 (2009).
58. Park, J. Y., Daksha, P., Lee, G. H., Woo, S. & Chang, Y. Highly water-dispersible PEG surface modified ultra small superparamagnetic iron oxide nanoparticles useful for target-specific biomedical applications. Nanotechnology 19, 365603 (2008).
59. Baek, M. J. et al. Water-solubleMnOnanocolloids for amolecular T1MRimaging: a facile one-pot synthesis, in vivo T1 MR images, and account for relaxivities. ACS Appl. Mater. Interfaces 2, 2949-2955 (2010).
60. Shunmugam, R. & Tew, G. N. Unique emission from polymer based lanthanide alloys. J. Am. Chem. Soc. 127, 13567-13572 (2005). (Pubitemid 41401209)
61. Bazzi, R. et al. Synthesis and properties of europium-based phosphors on the nanometer scale: Eu2O3, Gd2O3:Eu, and Y2O3:Eu. J. Colloid Interface Sci. 273, 191-197 (2004).
62. Zhang, W.-W. et al. Optical properties of nanocrystalline Y2O3:Eu depending on its odd structure. J. Colloid Interface Sci. 262, 588-593 (2003). (Pubitemid 36637018)
63. Brouwer, A. M. Standards for photoluminescence quantum yield measurements in solution (IUPAC Technical Report). Pure Appl. Chem. 83, 2213-2228 (2011).
64. Hasegawa, Y. et al. Enhanced luminescence and photomagnetic properties of surface-modified EuO nanocrystals. Angew. Chem. Int. Ed. 41, 2073-2075 (2002). (Pubitemid 34746908)
65. Stouwdam, J.W., Hebbink, G. A.,Huskens, J.& van Veggel, F. C. J. M. Lanthanidedoped nanoparticles with excellent luminescent properties in organic media. Chem. Mater. 15, 4604-4616 (2003).